1. Home
  2. GLSI vs IDN Comparison

GLSI vs IDN Comparison

Compare GLSI & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLSI
  • IDN
  • Stock Information
  • Founded
  • GLSI 2006
  • IDN 1994
  • Country
  • GLSI United States
  • IDN United States
  • Employees
  • GLSI N/A
  • IDN N/A
  • Industry
  • GLSI Biotechnology: Pharmaceutical Preparations
  • IDN Computer Software: Prepackaged Software
  • Sector
  • GLSI Health Care
  • IDN Technology
  • Exchange
  • GLSI Nasdaq
  • IDN Nasdaq
  • Market Cap
  • GLSI 133.4M
  • IDN 120.5M
  • IPO Year
  • GLSI 2020
  • IDN 1999
  • Fundamental
  • Price
  • GLSI $9.27
  • IDN $5.18
  • Analyst Decision
  • GLSI Strong Buy
  • IDN Strong Buy
  • Analyst Count
  • GLSI 1
  • IDN 3
  • Target Price
  • GLSI $39.00
  • IDN $5.83
  • AVG Volume (30 Days)
  • GLSI 37.8K
  • IDN 481.3K
  • Earning Date
  • GLSI 08-13-2025
  • IDN 08-07-2025
  • Dividend Yield
  • GLSI N/A
  • IDN N/A
  • EPS Growth
  • GLSI N/A
  • IDN N/A
  • EPS
  • GLSI N/A
  • IDN N/A
  • Revenue
  • GLSI N/A
  • IDN $20,211,000.00
  • Revenue This Year
  • GLSI N/A
  • IDN $9.35
  • Revenue Next Year
  • GLSI N/A
  • IDN $13.05
  • P/E Ratio
  • GLSI N/A
  • IDN N/A
  • Revenue Growth
  • GLSI N/A
  • IDN 4.55
  • 52 Week Low
  • GLSI $8.06
  • IDN $1.92
  • 52 Week High
  • GLSI $18.15
  • IDN $6.49
  • Technical
  • Relative Strength Index (RSI)
  • GLSI 42.26
  • IDN 54.30
  • Support Level
  • GLSI $8.67
  • IDN $5.21
  • Resistance Level
  • GLSI $9.37
  • IDN $5.66
  • Average True Range (ATR)
  • GLSI 0.28
  • IDN 0.34
  • MACD
  • GLSI 0.00
  • IDN -0.11
  • Stochastic Oscillator
  • GLSI 28.74
  • IDN 21.35

About GLSI Greenwich LifeSciences Inc.

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.

About IDN Intellicheck Inc.

Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.

Share on Social Networks: